Cargando…

Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension

OBJECTIVES: SSc-associated pulmonary arterial hypertension (SSc-APAH) is a late but devastating complication of SSc. Early identification of SSc-APAH may improve survival. We examined the role of circulating miRNAs in SSc-APAH. METHODS: Using quantitative RT-PCR the abundance of mature miRNAs in pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wuttge, Dirk M, Carlsen, Anting L, Teku, Gabriel, Wildt, Marie, Rådegran, Göran, Vihinen, Mauno, Heegaard, Niels H H, Hesselstrand, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742821/ https://www.ncbi.nlm.nih.gov/pubmed/33784391 http://dx.doi.org/10.1093/rheumatology/keab300

Ejemplares similares

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Simulation of the Dynamics of Primary Immunodeficiencies in B Cells
por: Teku, Gabriel Ndipagbornchi, et al.
Publicado: (2018)

Pan-cancer analysis of neoepitopes
por: Teku, Gabriel N., et al.
Publicado: (2018)

Simulation of the dynamics of primary immunodeficiencies in CD4+ T-cells
por: Teku, Gabriel N., et al.
Publicado: (2017)

Identification of core T cell network based on immunome interactome
por: Teku, Gabriel N, et al.
Publicado: (2014)

Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se
por: Lindholm, Anthony, et al.
Publicado: (2019)

Airway resistance and reactance are affected in systemic sclerosis
por: Aronsson, David, et al.
Publicado: (2015)

Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment
por: Hjalmarsson, Clara, et al.
Publicado: (2021)

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2019)

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study
por: Hamberg, Viggo, et al.
Publicado: (2023)

Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke
por: Sørensen, Sofie Sølvsten, et al.
Publicado: (2017)

Type III, IV, and VI Collagens Turnover in Systemic Sclerosis – a Longitudinal Study
por: Juhl, Pernille, et al.
Publicado: (2020)

Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2018)

Coping, social support and information in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A 2-year retrospective cohort study
por: Ivarsson, Bodil, et al.
Publicado: (2018)

Pulmonary blood density quantified by CMR is reduced in newly diagnosed systemic sclerosis, consistent with pulmonary arteriolar proliferation
por: Kanski, Mikael, et al.
Publicado: (2011)

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational study
por: Andréasson, Kristofer, et al.
Publicado: (2020)

Diurnal Variations of Human Circulating Cell-Free Micro-RNA
por: Heegaard, Niels H. H., et al.
Publicado: (2016)

Perceptions of Received Information, Social Support, and Coping in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2014)

Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals – a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes
por: Kanski, Mikael, et al.
Publicado: (2013)

Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2019)

Right atrial volume measured by cardiac magnetic resonance correlates with NT-ProBNP and invasive right atrial pressure in pulmonary hypertension, with and without systemic sclerosis
por: Gyllenhammar, Tom, et al.
Publicado: (2016)

Myocardial perfusion using cardiac magnetic resonance: Evidence of decreased global myocardial perfusion in patients with systemic sclerosis with possible gender differences
por: Gyllenhammar, Tom, et al.
Publicado: (2016)

Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2022)

Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study
por: Gyllenhammar, Tom, et al.
Publicado: (2018)

Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre‐capillary pulmonary hypertension
por: Bredfelt, Anna, et al.
Publicado: (2018)

Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2023)

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
por: Hesselstrand, Roger, et al.
Publicado: (2021)

Is It worth Considering Circulating microRNAs in Multiple Sclerosis?
por: Jagot, Ferdinand, et al.
Publicado: (2016)

Atrioventricular plane displacement and regional function to predict outcome in pulmonary arterial hypertension
por: Lindholm, Anthony, et al.
Publicado: (2022)

High frequency ultrasound of skin involvement in systemic sclerosis – a follow-up study
por: Hesselstrand, Roger, et al.
Publicado: (2015)

Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease
por: Wuttge, Dirk M, et al.
Publicado: (2007)

Underfilling decreases left ventricular function in pulmonary arterial hypertension
por: Sjögren, Hannah, et al.
Publicado: (2021)

Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
por: Hansen, T F, et al.
Publicado: (2015)

The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes
por: Radstake, Timothy R. D. J., et al.
Publicado: (2009)

Predicting mortality during long-term follow-up in pulmonary arterial hypertension
por: Kylhammar, David, et al.
Publicado: (2021)

Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy: a registry-based study
por: Hjalmarsson, Clara, et al.
Publicado: (2020)

Longitudinal changes in risk status in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2020)

Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass
por: Oliveira, Douglas Nogueira Perez, et al.
Publicado: (2019)

How to evaluate performance of prediction methods? Measures and their interpretation in variation effect analysis
por: Vihinen, Mauno
Publicado: (2012)

Variation Ontology for annotation of variation effects and mechanisms
por: Vihinen, Mauno
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_51vp0hii73tmtgjuj8n3hbej8k